5[5]Murray Hw.Current and future clinical applications of interfer on-gamma in host antimicrobial defense[J].Intensive Care Med,1996,22(4):S456-S461.
6[6]Colo C,Varela G,Hemgndez V,et al.Use of recombinant inter feron gamma in pediatric patients with juvenile chronic arthritis[J].Biotherapy,1998,11:15-20.
二级参考文献18
1中华人民共和国卫生部.小儿肺炎防治方案[J].中华儿科杂志,1987,25:47-47.
2[3]Behrman RE, Kilegman RM, Jenson HB. Nelson Textbook of Pediatrics. 16th ed. Philadelphia:WB Saunders,2001: 991- 993.
3[4]Editorials. Therapy for bronchiolitis: Help wanted. J Pediatr, 1997, 130(2): 170- 174.
4Walsh E E，J Infect Dis，1997年，175卷，814页
5Gutierrez, KM,Prober, CG.Encephalitis. Identifying the specificcause is key to effective management[].Postgraduate Medicine.1998
6Whitley RJ,Gnann JW.Viral encephalitis: familiar infections and emerging pathogens[].The Lancet.2002
7Chua K B,Goh K J,Wong K T,et al.Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia[].The Lancet.1999
8Whitley R J,Roizman B.Herpes simplex virus infections[].Lancet The.2001
9Hofgartner WT,Huhmer AFR,Landers JP,et al.Rapid diagnosis of herpes simplex encephalitis using microchip electrophoresis of PCR products[].Clinical Chemistry.1999
10Redington JJ,Tyler KL.Viral infections of the nervous system, 2002;update on diagnosis and treatmen[].Archives of Neurology.2002
9Graham B S. Biological challenges and technological opportu nities for respiratory syncytial virus vaccine development[J]. Immunol Rev, 2011,239(1) :149-166.
10Kotenko SV, Gallagher G, Baurin VV, et al .IFN lambdas- mediate antiviral protection through a distinct class II cytokinereceptor complex[J]. Nat Immunol, 2003,4(1) :69-77.
